Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New use claimed by Sanofi-Synthelabo for succinic acid derivatives

Dec. 21, 2000

Commencement of phase I trial of IL-1 Trap for rheumatoid arthritis announced by Regeneron

Dec. 21, 2000

University of Utah to evaluate efficacy of glucosamine and chondroitin in treating OA

Dec. 20, 2000

Kaken patents new series with potential utility in inflammation, osteoporosis

Dec. 19, 2000

Anti-TNF-alpha MAb effective against spondyloarthropathy associated with Crohn's disease

Dec. 18, 2000

Recent patent covers selective COX-2 inhibitors synthesized at Merck Frosst

Dec. 15, 2000

Genmab moves HuMax-CD4 for RA to phase II

Dec. 15, 2000

Arakis and Penwest combine expertise to develop novel chronotherapeutic product for RA

Dec. 15, 2000

Profile of new COX-2 inhibitor discussed at Japanese medicinal chemistry meeting

Dec. 14, 2000

Recent Japanese patent reveals new TNF-alpha inhibitors from Snow Brand

Dec. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...